RBF provides leading biotech, biopharma, medical technology, and healthcare services companies with bespoke, non-dilutive financing, backed by Asia-sourced healthcare royalty / revenue interests, or through a range of alternative financing structures. It is managed by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore.
With a hybrid structure, this newly closed facility relies on both recallable and uncalled capital from investors of RBF and the performance of the investments made by RBF.
The Reed Smith team advising on the deal was led by partners Leon Stephenson and Colin Baker, supported by partners Omar Al-Ali, Chris Davis and Michael Sinn; counsel Andrea Dinamarco and Crystal Li; associates Miriam Bandera, Chloe Benton, Sylvia Cherem, Yvette Ho, Ho Yan Ko, Hannah Onifade, Philip Orme, Dimitrios Pittas, Tim Ramos, Natalie Sharkey, Ping Ting Tan; trainees James Allen and Oscar Liot, and Carolyn Chia consultant at Reed Smith’s formal law alliance in Singapore, Resource Law LLC.
Leon Stephenson, partner and client relationship lead for Natixis CIB, commented: “We are delighted to have supported Natixis CIB on the closing of this bespoke hybrid facility. This deal was perfect for our global funds finance team and enabled us to put together a transaction team of funds finance lawyer located in our London, US, Hong Kong and, Singapore offices.”
Mourant Ozannes (Hong Kong) acted as Cayman Islands legal counsel for Natixis CIB.